THE INCIDENCE OF SIDE EFFECTS WITH AMIODARONE IS HIGH Newsletter Article 14 February 2013 Pages: 4 - 4
NO POSITIVE ASSOCIATION BETWEEN ORAL CONTRACEPTIVE USE AND BREAST CANCER Newsletter Article 14 February 2013 Pages: 4 - 5
LITHIUM THERAPY MIGHT GIVE RISE TO VARIOUS SKIN CONDITIONS Newsletter Article 14 February 2013 Pages: 5 - 5
DOXPICOMINE: compared with pethidine for pain relief Newsletter Article 14 February 2013 Pages: 6 - 6
FOR SPEED OF ACTION, AMOXAPINE BEATS DOXEPIN IN DEPRESSION Newsletter Article 14 February 2013 Pages: 7 - 7
TWO ASSESSMENTS OF CO-TRIMOXAZOLE FOR PROPHYLACTIC PURPOSES Newsletter Article 14 February 2013 Pages: 7 - 8
DIPHENHYDRAMINE BENEFITS MODERATELY INSOMNIAC PATIENTS Newsletter Article 14 February 2013 Pages: 8 - 8
ALBENDAZOLE: AN ANTHELMINTIC NOW RELEASED IN SE ASIA AND ZIMBABWE Newsletter Article 14 February 2013 Pages: 8 - 9
RENAL IMPAIRMENT AND THE ELIMINATION OF VARIOUS DRUGS Newsletter Article 14 February 2013 Pages: 10 - 11
CICLAZINDOL: AN ORAL HYPOGLYCAEMIC AND APPETITE SUPPRESSANT ALL IN ONE? Newsletter Article 14 February 2013 Pages: 11 - 11
DAPSONE ACCELERATES THE RESOLUTION OF MILIARY LUPUS OF THE FACE Newsletter Article 14 February 2013 Pages: 12 - 12
MIGHT BENOXAPROFEN HAVE HAD SOME USE IN PSORIASIS? Newsletter Article 14 February 2013 Pages: 12 - 12
DUODENAL ULCERS: APPROACHES TO TREATMENT AND MAINTENANCE Newsletter Article 14 February 2013 Pages: 12 - 13
CEPHAPIRIN IS EFFECTIVE IN THE TREATMENT OF STAPHYLOCOCCAL ENDOCARDITIS Newsletter Article 14 February 2013 Pages: 13 - 13
DISSOLVING BILIARY DUCT STONES WITH URSODEOXYCHOLIC ACID Newsletter Article 14 February 2013 Pages: 14 - 14
WILL ALPROSTADIL PROTECT PLATELETS DURING BYPASS SURGERY? Newsletter Article 14 February 2013 Pages: 14 - 14
THERE IS NO EVIDENCE OF AUTOINDUCTION OF MORPHINE IN CANCER PATIENTS Newsletter Article 14 February 2013 Pages: 14 - 14
RECTAL METRONIDAZOLE GIVES THERAPEUTIC BLOOD LEVELS IN THE SEVERELY ILL Newsletter Article 14 February 2013 Pages: 15 - 15
SOME GOOD ‘NEGATIVE’ FINDINGS WITH H2-BLOCKER PHARMACOLOGY Newsletter Article 14 February 2013 Pages: 15 - 15
CEFOPERAZONE ELIMINATION IN PATIENTS WITH DISTURBED HEPATOBILIARY FUNCTION Newsletter Article 14 February 2013 Pages: 15 - 15
THE PHARMACOKINETICS AND DYNAMICS OF ATENOLOL - A DOSE RESPONSE STUDY Newsletter Article 14 February 2013 Pages: 16 - 16
CEFMENOXIME: third generation cephalosporin recently marketed in Japan by Takeda and in Germany by Grunenthal (continued) Newsletter Article 14 February 2013 Pages: 19 - 19
PIPOTHIAZINE PALMITATE: depot antipsychotic now introduced in the UK by May and Baker Newsletter Article 14 February 2013 Pages: 19 - 20